Reporting
Filter By:
Completed
CTN 277: CARMA endo study
Endocrinopathy & cellular aging in women and girls enrolled in the CARMA cohort
Learn MoreEnrolling
CTN 272-2: The Canadian HIV & Aging Cohort Study 2.0
Discovering pathways to successful aging in people living with HIV
Learn MoreReporting
CTN 262: Canadian HIV women’s sexual and reproductive health cohort study (CHIWOS)
Canadian HIV women’s sexual and reproductive health cohort study
Learn MoreOngoing
CTN 236: HPV vaccine in HIV positive girls and women
A study of an HPV VLP vaccine in a cohort of HIV positive girls and women
Learn MoreReporting
CTN 233: Pharmacokinetics of antiretroviral therapy (ARV) in HIV-positive women
Predictors of antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy
Learn MoreReporting
CTNPT 025: ProSPAR
Progesterone Supplementation for HIV-positive Pregnant Women on Anti-Retrovirals
Learn MoreCTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.